LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Poly(A)-specific ribonuclease PARN

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Poly(A)-specific ribonuclease PARN
Gene product:
poly(A)-specific ribonuclease PARN, putative
Species:
Leishmania mexicana
UniProt:
E9AU71_LEIMU
TriTrypDb:
LmxM.36.6350
Length:
510

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 15
NetGPI no yes: 0, no: 15
Cellular components
Term Name Level Count
GO:0005634 nucleus 5 1
GO:0005737 cytoplasm 2 2
GO:0043226 organelle 2 1
GO:0043227 membrane-bounded organelle 3 1
GO:0043229 intracellular organelle 3 1
GO:0043231 intracellular membrane-bounded organelle 4 1
GO:0110165 cellular anatomical entity 1 2

Expansion

Sequence features

E9AU71
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: E9AU71

Function

Could not find GO biological_process term for this entry.
Molecular functions
Term Name Level Count
GO:0003676 nucleic acid binding 3 16
GO:0005488 binding 1 16
GO:0097159 organic cyclic compound binding 2 16
GO:1901363 heterocyclic compound binding 2 16
GO:0000175 3'-5'-RNA exonuclease activity 7 3
GO:0003723 RNA binding 4 2
GO:0003824 catalytic activity 1 3
GO:0004518 nuclease activity 4 3
GO:0004527 exonuclease activity 5 3
GO:0004532 RNA exonuclease activity 5 3
GO:0004540 RNA nuclease activity 4 3
GO:0008408 3'-5' exonuclease activity 6 3
GO:0016787 hydrolase activity 2 3
GO:0016788 hydrolase activity, acting on ester bonds 3 3
GO:0016796 exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters 6 3
GO:0016896 RNA exonuclease activity, producing 5'-phosphomonoesters 6 3
GO:0140098 catalytic activity, acting on RNA 3 3
GO:0140640 catalytic activity, acting on a nucleic acid 2 3
GO:0004535 poly(A)-specific ribonuclease activity 8 1

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_NRD_NRD_1 178 180 PF00675 0.267
CLV_NRD_NRD_1 186 188 PF00675 0.246
CLV_NRD_NRD_1 225 227 PF00675 0.317
CLV_NRD_NRD_1 249 251 PF00675 0.286
CLV_NRD_NRD_1 321 323 PF00675 0.321
CLV_NRD_NRD_1 444 446 PF00675 0.629
CLV_NRD_NRD_1 481 483 PF00675 0.533
CLV_PCSK_KEX2_1 178 180 PF00082 0.283
CLV_PCSK_KEX2_1 186 188 PF00082 0.283
CLV_PCSK_KEX2_1 224 226 PF00082 0.327
CLV_PCSK_KEX2_1 320 322 PF00082 0.321
CLV_PCSK_KEX2_1 481 483 PF00082 0.435
CLV_PCSK_KEX2_1 54 56 PF00082 0.282
CLV_PCSK_PC1ET2_1 224 226 PF00082 0.250
CLV_PCSK_PC1ET2_1 54 56 PF00082 0.291
CLV_PCSK_SKI1_1 134 138 PF00082 0.253
CLV_PCSK_SKI1_1 281 285 PF00082 0.342
DEG_APCC_DBOX_1 95 103 PF00400 0.529
DEG_MDM2_SWIB_1 239 247 PF02201 0.432
DEG_Nend_UBRbox_2 1 3 PF02207 0.351
DOC_CKS1_1 135 140 PF01111 0.338
DOC_MAPK_gen_1 186 194 PF00069 0.446
DOC_MAPK_gen_1 231 239 PF00069 0.529
DOC_MAPK_gen_1 469 476 PF00069 0.456
DOC_MIT_MIM_1 477 487 PF04212 0.419
DOC_PP4_FxxP_1 43 46 PF00568 0.452
DOC_USP7_MATH_1 160 164 PF00917 0.530
DOC_USP7_MATH_1 388 392 PF00917 0.468
DOC_USP7_MATH_1 416 420 PF00917 0.330
DOC_USP7_UBL2_3 207 211 PF12436 0.338
DOC_USP7_UBL2_3 349 353 PF12436 0.529
DOC_WW_Pin1_4 134 139 PF00397 0.338
DOC_WW_Pin1_4 268 273 PF00397 0.414
DOC_WW_Pin1_4 489 494 PF00397 0.567
LIG_14-3-3_CanoR_1 178 184 PF00244 0.468
LIG_14-3-3_CanoR_1 191 195 PF00244 0.549
LIG_14-3-3_CanoR_1 320 326 PF00244 0.529
LIG_14-3-3_CanoR_1 445 450 PF00244 0.528
LIG_14-3-3_CanoR_1 481 487 PF00244 0.447
LIG_14-3-3_CanoR_1 96 102 PF00244 0.534
LIG_APCC_ABBA_1 136 141 PF00400 0.400
LIG_BIR_III_2 305 309 PF00653 0.421
LIG_BRCT_BRCA1_1 326 330 PF00533 0.461
LIG_BRCT_BRCA1_1 39 43 PF00533 0.421
LIG_BRCT_BRCA1_1 390 394 PF00533 0.502
LIG_FHA_1 115 121 PF00498 0.525
LIG_FHA_1 406 412 PF00498 0.376
LIG_FHA_1 431 437 PF00498 0.605
LIG_FHA_1 76 82 PF00498 0.518
LIG_FHA_2 128 134 PF00498 0.395
LIG_FHA_2 159 165 PF00498 0.442
LIG_FHA_2 30 36 PF00498 0.460
LIG_FHA_2 300 306 PF00498 0.487
LIG_FHA_2 308 314 PF00498 0.531
LIG_FHA_2 70 76 PF00498 0.483
LIG_GBD_Chelix_1 176 184 PF00786 0.252
LIG_GBD_Chelix_1 366 374 PF00786 0.296
LIG_LIR_Apic_2 331 337 PF02991 0.445
LIG_LIR_Apic_2 40 46 PF02991 0.450
LIG_LIR_Gen_1 23 31 PF02991 0.415
LIG_LIR_Gen_1 274 284 PF02991 0.513
LIG_LIR_Gen_1 391 401 PF02991 0.215
LIG_LIR_Gen_1 4 13 PF02991 0.504
LIG_LIR_Gen_1 460 470 PF02991 0.345
LIG_LIR_Gen_1 59 69 PF02991 0.460
LIG_LIR_Nem_3 23 27 PF02991 0.387
LIG_LIR_Nem_3 274 280 PF02991 0.457
LIG_LIR_Nem_3 356 362 PF02991 0.456
LIG_LIR_Nem_3 391 397 PF02991 0.351
LIG_LIR_Nem_3 4 9 PF02991 0.466
LIG_LIR_Nem_3 460 466 PF02991 0.334
LIG_LIR_Nem_3 59 64 PF02991 0.454
LIG_MAD2 244 252 PF02301 0.529
LIG_MLH1_MIPbox_1 390 394 PF16413 0.304
LIG_PCNA_yPIPBox_3 96 105 PF02747 0.421
LIG_Pex14_2 239 243 PF04695 0.451
LIG_SH2_CRK 334 338 PF00017 0.515
LIG_SH2_STAP1 131 135 PF00017 0.536
LIG_SH2_STAP1 188 192 PF00017 0.452
LIG_SH2_STAP1 359 363 PF00017 0.455
LIG_SH2_STAT3 201 204 PF00017 0.513
LIG_SH2_STAT5 201 204 PF00017 0.489
LIG_SH2_STAT5 277 280 PF00017 0.543
LIG_SH2_STAT5 393 396 PF00017 0.448
LIG_SH2_STAT5 87 90 PF00017 0.454
LIG_SH3_3 7 13 PF00018 0.514
LIG_SUMO_SIM_par_1 499 506 PF11976 0.361
LIG_SUMO_SIM_par_1 8 14 PF11976 0.477
LIG_TRAF2_1 130 133 PF00917 0.476
LIG_TRFH_1 334 338 PF08558 0.529
LIG_WRC_WIRS_1 101 106 PF05994 0.421
LIG_WRC_WIRS_1 180 185 PF05994 0.421
LIG_WRC_WIRS_1 463 468 PF05994 0.462
MOD_CK1_1 100 106 PF00069 0.510
MOD_CK1_1 190 196 PF00069 0.544
MOD_CK1_1 324 330 PF00069 0.452
MOD_CK1_1 492 498 PF00069 0.554
MOD_CK2_1 127 133 PF00069 0.469
MOD_CK2_1 158 164 PF00069 0.534
MOD_CK2_1 179 185 PF00069 0.362
MOD_CK2_1 217 223 PF00069 0.517
MOD_CK2_1 307 313 PF00069 0.529
MOD_CK2_1 69 75 PF00069 0.472
MOD_GlcNHglycan 117 120 PF01048 0.265
MOD_GlcNHglycan 345 348 PF01048 0.289
MOD_GlcNHglycan 386 389 PF01048 0.431
MOD_GlcNHglycan 390 393 PF01048 0.441
MOD_GlcNHglycan 91 94 PF01048 0.325
MOD_GSK3_1 287 294 PF00069 0.467
MOD_GSK3_1 324 331 PF00069 0.569
MOD_GSK3_1 34 41 PF00069 0.449
MOD_GSK3_1 384 391 PF00069 0.369
MOD_GSK3_1 426 433 PF00069 0.484
MOD_GSK3_1 457 464 PF00069 0.465
MOD_GSK3_1 492 499 PF00069 0.487
MOD_GSK3_1 71 78 PF00069 0.466
MOD_N-GLC_1 343 348 PF02516 0.332
MOD_N-GLC_1 75 80 PF02516 0.221
MOD_N-GLC_1 89 94 PF02516 0.329
MOD_N-GLC_1 97 102 PF02516 0.329
MOD_NEK2_1 1 6 PF00069 0.411
MOD_NEK2_1 147 152 PF00069 0.338
MOD_NEK2_1 206 211 PF00069 0.498
MOD_NEK2_1 246 251 PF00069 0.450
MOD_NEK2_1 284 289 PF00069 0.549
MOD_NEK2_1 97 102 PF00069 0.566
MOD_PIKK_1 271 277 PF00454 0.384
MOD_PIKK_1 328 334 PF00454 0.570
MOD_PIKK_1 431 437 PF00454 0.417
MOD_PKA_1 321 327 PF00069 0.338
MOD_PKA_1 445 451 PF00069 0.421
MOD_PKA_1 461 467 PF00069 0.296
MOD_PKA_2 190 196 PF00069 0.376
MOD_PKA_2 321 327 PF00069 0.432
MOD_Plk_1 1 7 PF00069 0.349
MOD_Plk_1 127 133 PF00069 0.453
MOD_Plk_1 343 349 PF00069 0.429
MOD_Plk_1 75 81 PF00069 0.520
MOD_Plk_1 97 103 PF00069 0.421
MOD_Plk_2-3 127 133 PF00069 0.338
MOD_Plk_2-3 217 223 PF00069 0.452
MOD_Plk_2-3 75 81 PF00069 0.518
MOD_Plk_4 147 153 PF00069 0.409
MOD_Plk_4 179 185 PF00069 0.530
MOD_Plk_4 287 293 PF00069 0.496
MOD_Plk_4 405 411 PF00069 0.379
MOD_Plk_4 46 52 PF00069 0.375
MOD_Plk_4 496 502 PF00069 0.389
MOD_Plk_4 97 103 PF00069 0.531
MOD_ProDKin_1 134 140 PF00069 0.338
MOD_ProDKin_1 268 274 PF00069 0.414
MOD_ProDKin_1 489 495 PF00069 0.562
MOD_SUMO_rev_2 127 136 PF00179 0.486
MOD_SUMO_rev_2 274 283 PF00179 0.494
MOD_SUMO_rev_2 290 297 PF00179 0.425
TRG_ENDOCYTIC_2 277 280 PF00928 0.445
TRG_ENDOCYTIC_2 463 466 PF00928 0.461
TRG_ENDOCYTIC_2 61 64 PF00928 0.460
TRG_ER_diArg_1 178 180 PF00400 0.520
TRG_ER_diArg_1 186 188 PF00400 0.522
TRG_ER_diArg_1 225 227 PF00400 0.536
TRG_ER_diArg_1 320 322 PF00400 0.522
TRG_ER_diArg_1 481 483 PF00400 0.533
TRG_NES_CRM1_1 2 14 PF08389 0.303
TRG_Pf-PMV_PEXEL_1 225 230 PF00026 0.307
TRG_Pf-PMV_PEXEL_1 445 450 PF00026 0.578

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N0P603 Leptomonas seymouri 56% 99%
A0A0N1ILJ1 Leptomonas seymouri 26% 84%
A0A0S4IMW3 Bodo saltans 23% 100%
A0A0S4IR41 Bodo saltans 22% 80%
A0A0S4J225 Bodo saltans 35% 70%
A0A1X0NLC6 Trypanosomatidae 33% 99%
A0A3Q8ICI3 Leishmania donovani 26% 85%
A0A3R7K5K5 Trypanosoma rangeli 36% 98%
A0A3S7XC77 Leishmania donovani 90% 100%
A0A422N5N5 Trypanosoma rangeli 28% 86%
A4HCS6 Leishmania braziliensis 27% 100%
A4HQF5 Leishmania braziliensis 75% 100%
A4I0A0 Leishmania infantum 26% 85%
A4IC91 Leishmania infantum 91% 100%
B2RXZ1 Mus musculus 23% 96%
C9ZV58 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 29% 87%
C9ZZC3 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 23% 82%
D0A3T2 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 33% 100%
E9AW65 Leishmania mexicana (strain MHOM/GT/2001/U1103) 27% 86%
H9JAQ7 Bombyx mori 25% 96%
O95453 Homo sapiens 25% 80%
P69341 Bos taurus 25% 80%
Q21412 Caenorhabditis elegans 23% 90%
Q4Q0C3 Leishmania major 88% 100%
Q4QBB3 Leishmania major 27% 100%
Q5R6R6 Pongo abelii 25% 98%
Q5RC51 Pongo abelii 25% 80%
Q7ZU92 Danio rerio 27% 77%
Q8NA58 Homo sapiens 25% 98%
Q8VDG3 Mus musculus 25% 82%
Q90ZA1 Xenopus laevis 25% 81%
V5ASU9 Trypanosoma cruzi 35% 99%
V5BCG2 Trypanosoma cruzi 26% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS